A Prospective, Multicenter, Randomized, Double-blind, Vehicle-controlled Phase 2 Study to Evaluate the Safety and Efficacy of a Combination Of 3% Minocycline and 0.3% Adapalene Topical Foam Formulation for the Treatment of Moderate-to-Severe Acne. J of Skin [Internet]. 2020 Oct. 27 [cited 2026 Apr. 30];4(6):s90. Available from: https://skin.dermsquared.com/skin/article/view/1060